344
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma

, , , , , , , , , , , & show all
Pages 2558-2562 | Received 16 Nov 2018, Accepted 11 Feb 2019, Published online: 08 Mar 2019
 

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1585836.

Additional information

Funding

This work was supported by the Leukemia and Lymphoma Society (6551-18), the American Cancer Society (127508-RSG-15-045-01-LIB), the UWCCC Trillium Fund for Myeloma Research and the NIH (P30CA014520).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.